On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases
Small · 2026
DOI: 10.1002/smll.202514520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Kenji Kajitani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Erythrocyte Deformability, Hematologic Diseases, Erythrocytes, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI.
Abstract (Originalsprache)
This study introduces a novel method for evaluating red blood cell (RBC) deformability using a microfluidic platform equipped with constriction channels that mimic capillary vessels. The normalized transit velocity of RBCs at 50% compression ratio (V^ ε = 0.5 ) is proposed as a quantitative index of RBC deformability. Experimental validation is conducted in two key phases. First, to validate the proposed index, a controlled reduction in RBC deformability is induced using varying concentrations of diamide. V^ ε = 0.5 progressively decrease as the diamide concentration increased, confirming that the index tracks changes in RBC deformability. Second, to demonstrate the ability of the platform to detect disease‐specific properties, RBCs from patients with iron deficiency anemia (IDA), thalassemia (Thal), and hereditary spherocytosis (HS) are analyzed. The results reveal elevated deformability from IDA and Thal patients, and reduced deformability from HS patients. High V^ ε = 0.5 values consistently correlate with RBC characteristics known to enhance deformability—such as thin, elliptical morphology, a high surface‐area‐to‐volume ratio, and low internal viscosity—whereas lower values are associated with characteristics that impair deformability. These findings highlight the impact of RBC characteristics on deformability and the importance of our microfluidic platform as a robust tool for investigating hematological diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
- Department of Mechanical Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
- Department of Mechanical Science and Bioengineering, Graduate School of Engineering Science, The University of Osaka, Toyonaka, Osaka, Japan.
- Faculty of Informatics and Management Science, University of Zilina, Univerzitna, Slovakia.
- Department of Hematology and Oncology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
ORCID-Profile: Kenji Kajitani, Tomohito Ohtani, Ivan Cimrák
Förderung
- Japan Society for the Promotion of Science (JSPS) KAKENHI
Zitieren
APA
Kajitani, K., Tsai, C. D., Ohtani, T., Wada, S., Cimrák, I., Chimura, M., Taniguchi, T., Ueda, Y., Nishimura, J. I., & Sakata, Y. (2026). On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases. Small. https://doi.org/10.1002/smll.202514520
Vancouver
Kajitani K, Tsai CD, Ohtani T, Wada S, Cimrák I, Chimura M, et al. On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases. Small. 2026. doi:10.1002/smll.202514520
BibTeX
@article{Kajitani2026,
author = {Kajitani, Kenji and Tsai, Chia-Hung Dylan and Ohtani, Tomohito and Wada, Shigeo and Cimrák, Ivan and Chimura, Misato and Taniguchi, Tatsunori and Ueda, Yasutaka and Nishimura, Jun-Ichi and Sakata, Yasushi},
title = {On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202514520}
}
EUVIMED